Prev Close | 125.05 |
Day Low/High | 122.12 / 129.80 |
52 Wk Low/High | 6.26 / 189.40 |
Prev Close | 125.05 |
Day Low/High | 122.12 / 129.80 |
52 Wk Low/High | 6.26 / 189.40 |
Exchange | NASDAQ |
Shares Outstanding | 63.66B |
Market Cap | 7.96B |
P/E Ratio | N/A |
Div & Yield | N.A. (N.A) |
Stocks move cautiously higher as investors wait for direction from a number of market-churning events tomorrow.
Things were looking up and then today happened.
It's safe to say these guys know what they are doing.
"Such ingratitude, after all the times I saved your life." -- Blondie, THE GOOD THE BAD THE UGLY Let's run down the good, the bad and the ugly in today's market so far: THE GOOD Bonds are trading better today. The 10- and 30-year bond yields are dow...
I have followed Novavax for several years. After yesterday's market close the company announced the results of their Phase Three trial for a respiratory-virus drug. NVAX missed its goal, and the shares are trading down by about 80% ($8.40 to $1) i...
An update on some recent small biotech recommendations.
Each company has approaching catalysts.
Each company has approaching catalysts.
These are the biggest errors that I've made over the years.
Watch these names as stability returns to the sector.
Another strong market day. The issue of taxes was front and center today. Here are some of my takes: My Take on Corporate Taxes Man Up, Allergan Shareholders Who Loses in Pfizer/Allergan Deal's Demise? I remain manifestly bearish, in the belief ...
The iShares Nasdaq Biotechnology ETF (IBB) has tumbled from nearly $400 a share early last summer to around $240 at last check, so I'm taking advantage of today's market schmeissing to purchase a small position in a biotech (biowreck?). I'm buying a...
Jim Cramer talks oil, Citigroup, burger joints and biotechs.
However, utilities and some technology names bucked the trend.
Piper's best stock picks, and some festive drinks.
Just be patient and protect capital.
InterMune, Novavax have promising products and acquisition possibilities.
These smaller companies with recent insider buying look intriguing.
The best way to invest in this sector is to accumulate small positions in at least a dozen firms.